FDA全球物质注册数据库（FDA Global Substance Registration System）
物质名称NAXITAMAB
异名/同义词ANTI-GD2 IGG3 MONOCLONAL ANTIBODY 3F8 HUMANIZED
ANTI-GD2 MONOCLONAL ANTIBODY 3F8 HUMANIZED
DANYELZA
HU3F8
HUMANIZED 3F8
HUMANIZED ANTI-GD2 MONOCLONAL ANTIBODY 3F8
HUMANIZED MONOCLONAL ANTIBODY HU3F8-IGG1
IMMUNOGLOBULIN G1, ANTI-(GANGLIOSIDE GD2) (HUMANIZED MUS MUSCULUS CLONE HU3F8 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MUS MUSCULUS CLONE HU3F8 LIGHT-CHAIN, DIMER
MONOCLONAL ANTIBODY HU3F8
NAXITAMAB
NAXITAMAB [INN]
NAXITAMAB [USAN]
NAXITAMAB [WHO-DD]
NAXITAMAB GQGK [WHO-DD]
NAXITAMAB-GQGK
CAS登记号1879925-92-4
物质唯一标识(Unique Ingredient Identifier)9K8GNJ2874
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System